Nag et al., 2024 - Google Patents
Exploring the emerging trends in the synthesis and theranostic paradigms of cerium oxide nanoparticles (CeONPs): A comprehensive reviewNag et al., 2024
- Document ID
- 3627946675386150642
- Author
- Nag S
- Mitra O
- Sankarganesh P
- Bhattacharjee A
- Mohanto S
- Gowda B
- Kar S
- Ramaiah S
- Anbarasu A
- Ahmed M
- Publication year
- Publication venue
- Materials Today Chemistry
External Links
Snippet
Cerium oxide nanoparticles (CeONPs) have come to prominence as a highly intriguing and beneficial nanomaterial in an array of biomedical and theranostic applications, including prognostic measures, diagnosis, drug administration, bio-scaffolding, bioanalysis, and …
- 239000002105 nanoparticle 0 title abstract description 99
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shreyash et al. | Green synthesis of nanoparticles and their biomedical applications: a review | |
Nag et al. | Exploring the emerging trends in the synthesis and theranostic paradigms of cerium oxide nanoparticles (CeONPs): A comprehensive review | |
Długosz et al. | Methods for reducing the toxicity of metal and metal oxide NPs as biomedicine | |
Ahmed et al. | Bacterial toxicity of biomimetic green zinc oxide nanoantibiotic: insights into ZnONP uptake and nanocolloid–bacteria interface | |
Bandara et al. | Agricultural and biomedical applications of chitosan-based nanomaterials | |
Siddiqi et al. | Biogenic fabrication and characterization of silver nanoparticles using aqueous-ethanolic extract of lichen (Usnea longissima) and their antimicrobial activity | |
Saratale et al. | Exploiting fruit waste grape pomace for silver nanoparticles synthesis, assessing their antioxidant, antidiabetic potential and antibacterial activity against human pathogens: a novel approach | |
Annu et al. | Green synthesis of metal, metal oxide nanoparticles, and their various applications | |
Arif et al. | A review on recent developments in the biosynthesis of silver nanoparticles and its biomedical applications | |
Raj et al. | Biogenic synthesis of silver nanoparticles, characterization and their applications—a review | |
Hamida et al. | Lichens—A potential source for nanoparticles fabrication: A review on nanoparticles biosynthesis and their prospective applications | |
Shah et al. | Green synthesis of metallic nanoparticles via biological entities | |
Kulkarni et al. | Biofabrication of nanoparticles: sources, synthesis, and biomedical applications | |
Abbasi et al. | An intriguing approach toward antibacterial activity of green synthesized Rutin-templated mesoporous silica nanoparticles decorated with nanosilver | |
Omran et al. | Nanoantioxidants: pioneer types, advantages, limitations, and future insights | |
Dutta et al. | Bioengineered zinc oxide nanoparticles: Chemical, green, biological fabrication methods and its potential biomedical applications | |
Barbasz et al. | Cytotoxic activity of highly purified silver nanoparticles sol against cells of human immune system | |
Rana et al. | Recent advancements in plant-and microbe-mediated synthesis of metal and metal oxide nanomaterials and their emerging antimicrobial applications | |
Manikandan et al. | Biofabrication of ecofriendly copper oxide nanoparticles using Ocimum americanum aqueous leaf extract: analysis of in vitro antibacterial, anticancer, and photocatalytic activities | |
Rozhin et al. | Nanostructured ceria: Biomolecular templates and (bio) applications | |
Sysak et al. | Metal nanoparticle-flavonoid connections: synthesis, physicochemical and biological properties, as well as potential applications in medicine | |
Trivedi et al. | Recent advancements in plant-derived nanomaterials research for biomedical applications | |
Gatou et al. | Magnesium Oxide (MgO) Nanoparticles: Synthetic Strategies and Biomedical Applications | |
Wang et al. | Single and combined nanotoxicity of ZnO nanoparticles and graphene quantum dots against the microalga Heterosigma akashiwo | |
Balaji et al. | Padina boergesenii-mediated copper oxide nanoparticles synthesis, with their antibacterial and anticancer potential |